P5 EHealth : : an Agenda for the Health Technologies of the Future.
Saved in:
: | |
---|---|
TeilnehmendeR: | |
Place / Publishing House: | Cham : : Springer International Publishing AG,, 2019. ©2020. |
Year of Publication: | 2019 |
Edition: | 1st ed. |
Language: | English |
Online Access: | |
Physical Description: | 1 online resource (191 pages) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
5005987458 |
---|---|
ctrlnum |
(MiAaPQ)5005987458 (Au-PeEL)EBL5987458 (OCoLC)1135670456 |
collection |
bib_alma |
record_format |
marc |
spelling |
Pravettoni, Gabriella. P5 EHealth : an Agenda for the Health Technologies of the Future. 1st ed. Cham : Springer International Publishing AG, 2019. ©2020. 1 online resource (191 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier P5 eHealth: An Agenda for the Health Technologies of the Future -- Preface -- Contents -- About the Editors -- Part I: Foundations for P5 eHealth -- Chapter 1: A "P5" Approach to Healthcare and Health Technology -- 1 Introduction -- 2 P5 Medicine -- 3 eHealth -- 3.1 Strengths of eHealth -- 3.2 Criticalities of eHealth and Emerging Challenges -- 4 Conclusion -- References -- Chapter 2: The Development of iManageCancer: The Experience of a Personalised eHealth Platform for Cancer Patients' Empowerment -- 1 Introduction -- 2 The IManageCancer Platform -- 2.1 My HealthAvatar for iManageCancer -- 2.2 iManageMyHealth -- 2.3 iManageCancer Portal iPHR -- 2.4 Game for Adults -- 3 iManageCancer Within the p5 Approach -- 4 Conclusion -- References -- Part II: The 5 Ps and eHealth -- Chapter 3: The Prevention of Chronic Diseases Through eHealth: A Practical Overview -- 1 Introduction -- 2 Risk Factors for Chronic Diseases -- 3 Primary, Secondary, and Tertiary eHealth Prevention -- 4 Population-Based vs. Individual-Based eHealth Prevention -- 5 eHealth Behavioral Change Interventions -- 6 Strategies of eHealth Prevention -- 7 Conclusion -- References -- Chapter 4: An Introduction to Personalized eHealth -- 1 Introduction -- 1.1 What Are the News of Personalized Medicine? -- 1.2 A Brief History -- 2 The Development of Personalized Medicine -- 2.1 Treatments -- 2.2 Diagnosis and Risk Prediction -- 2.3 Doctor-Patient Communication -- 2.4 Disease/Illness Management -- 3 The Role of eHealth (and mHealth Specifically) -- 4 Liability: The Road Toward Becoming Active Patients -- 5 Communication Through eHealth -- 6 Health Social Networks -- 7 Challenges to eHealth Usages and Possible Solutions -- 8 Conclusion -- References -- Chapter 5: Predictive Precision Medicine: Towards the Computational Challenge -- 1 Introduction -- 2 Predictive Medicine and Precision Medicine. 3 Imaging Techniques, Artificial Intelligence and Machine Learning -- 3.1 Imaging Techniques -- 3.2 Artificial Intelligence and Machine Learning -- 3.3 Medical Imaging and Machine Learning -- 4 Predictive Precision Medicine in Neurodegenerative Diseases -- 4.1 Current Application: From Dementias to Parkinson's Disease -- 5 Conclusion -- References -- Chapter 6: Participatory Aspects of ICT Infrastructures for Cancer Management -- 1 Introduction -- 2 Participatory Aspects for Cancer Management -- 2.1 From Personalized to Participatory Medicine -- 2.2 Critical Factors of Participatory Medicine -- 2.3 Psychological Factors as Moderators of Participatory Medicine -- 3 ICT Solutions from Relevant EU Projects -- 3.1 iManageCancer -- 3.1.1 Technological Contribution -- 3.1.2 Participatory Aspect of the Developed Solution -- 3.1.3 Lessons Learnt -- 3.2 MyHealthAvatar -- 3.2.1 Technological Contribution -- 3.2.2 Participatory Aspect of the Developed Solution -- 3.2.3 Lessons Learnt -- 3.3 p-Medicine -- 3.3.1 Technological Contribution -- 3.3.2 Participatory Aspect of the Developed Solution -- 3.3.3 Lessons Learnt -- 3.4 EURECA -- 3.4.1 Technological Contribution -- 3.4.2 Participatory Aspects of the Developed Solution -- 3.4.3 Lessons Learnt -- 3.5 INTEGRATE -- 3.5.1 Technological Contribution -- 3.5.2 Participatory Aspect of the Developed Solution -- 3.5.3 Lessons Learnt -- 4 Conclusions and Guidelines for Future Development -- References -- Chapter 7: Psycho-cognitive Factors Orienting eHealth Development and Evaluation -- 1 The P5 and the Personomics Approach -- 2 The Key Elements for the P5-Personomics Approach -- 3 Solutions Come from the eHealth Apps -- 4 Digital Health in the Patient's Journey -- 4.1 A Possible Scenario -- 5 The Importance of Patient Education -- 6 Persuasive Design Technology -- 7 Conclusion -- References. Part III: Important Aspects for P5 Technologies Development and Utilization -- Chapter 8: Role of Next-Generation Sequencing Technologies in Personalized Medicine -- 1 Historic Background of DNA Sequencing -- 1.1 The NGS Revolution in the Context of Precision Medicine -- 2 Technical Aspects: From Sanger Sequencing to NGS -- 2.1 Library Preparation and Amplification -- 2.2 Sequencing -- 2.3 Data Analysis -- 3 NGS Methods: Genomics, Transcriptomics, and Epigenomics -- 3.1 Genomics -- 3.2 Transcriptomics -- 3.3 Epigenomics -- 4 NGS Applications for a Personalized Oncology -- 4.1 Detection of Driver Alterations and Resistance -- 4.1.1 Lung Cancer -- 4.1.2 Breast Cancer -- 4.1.3 Carcinoma of Unknown Primary Site -- 4.2 Biomarkers -- 4.2.1 Homologous Recombination Deficiency -- 4.2.2 Microsatellite Instability -- 4.2.3 Tumor Mutational Burden -- 4.3 Liquid Biopsy -- 4.3.1 Early Diagnosis of Primary Disease -- 4.3.2 Early Detection of Relapse -- 4.3.3 Detection of Driver/Resistance Mutations and Real-Time Monitoring of Therapies -- 4.3.4 Characterization of Tumor Heterogeneity -- 4.3.5 CTCs and ctDNA Analysis -- 5 NGS Implementation in Clinical Practice: Challenges and Limitations -- References -- Chapter 9: User-Centered Design Approaches and Methods for P5 eHealth -- 1 Introduction -- 2 From Ergonomics to User-Centered Design -- 2.1 Interaction Factors -- 2.2 Motivation and Emotion -- 2.2.1 Motivation in Design -- 2.2.2 Emotion in Design -- 2.3 Context -- 2.3.1 Individual and Psychosocial Dimensions of Context -- 2.3.2 Cultural and Relational Dimensions of Context -- 2.3.3 Physical and Material Dimension of Context -- 3 User-Centered Design and P5 eHealth -- References -- Chapter 10: Data Protection and Ethical Issues in European P5 eHealth -- 1 Introduction -- 2 eHealth in the European Union: From Advancement of Innovation to Data Protection Concerns. 3 The GDPR and Its Impact on eHealth Research and Innovation -- 3.1 The Accountability Principle and its Implications -- 3.2 Pseudonymization and Anonymization of Sensitive Data -- 3.3 The "Right Balance" Between Innovation and Protection of Individuals' Rights and Interests? -- 4 Ethical Issues in eHealth Technologies -- 4.1 Online eHealth (Self-Management) Tools -- 4.2 Monitoring Techniques -- 4.3 New and Unconventional eHealth Technologies -- 5 Conclusions -- References. Description based on publisher supplied metadata and other sources. Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. Electronic books. Triberti, Stefano. Print version: Pravettoni, Gabriella P5 EHealth: an Agenda for the Health Technologies of the Future Cham : Springer International Publishing AG,c2019 9783030279936 ProQuest (Firm) https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=5987458 Click to View |
language |
English |
format |
eBook |
author |
Pravettoni, Gabriella. |
spellingShingle |
Pravettoni, Gabriella. P5 EHealth : an Agenda for the Health Technologies of the Future. P5 eHealth: An Agenda for the Health Technologies of the Future -- Preface -- Contents -- About the Editors -- Part I: Foundations for P5 eHealth -- Chapter 1: A "P5" Approach to Healthcare and Health Technology -- 1 Introduction -- 2 P5 Medicine -- 3 eHealth -- 3.1 Strengths of eHealth -- 3.2 Criticalities of eHealth and Emerging Challenges -- 4 Conclusion -- References -- Chapter 2: The Development of iManageCancer: The Experience of a Personalised eHealth Platform for Cancer Patients' Empowerment -- 1 Introduction -- 2 The IManageCancer Platform -- 2.1 My HealthAvatar for iManageCancer -- 2.2 iManageMyHealth -- 2.3 iManageCancer Portal iPHR -- 2.4 Game for Adults -- 3 iManageCancer Within the p5 Approach -- 4 Conclusion -- References -- Part II: The 5 Ps and eHealth -- Chapter 3: The Prevention of Chronic Diseases Through eHealth: A Practical Overview -- 1 Introduction -- 2 Risk Factors for Chronic Diseases -- 3 Primary, Secondary, and Tertiary eHealth Prevention -- 4 Population-Based vs. Individual-Based eHealth Prevention -- 5 eHealth Behavioral Change Interventions -- 6 Strategies of eHealth Prevention -- 7 Conclusion -- References -- Chapter 4: An Introduction to Personalized eHealth -- 1 Introduction -- 1.1 What Are the News of Personalized Medicine? -- 1.2 A Brief History -- 2 The Development of Personalized Medicine -- 2.1 Treatments -- 2.2 Diagnosis and Risk Prediction -- 2.3 Doctor-Patient Communication -- 2.4 Disease/Illness Management -- 3 The Role of eHealth (and mHealth Specifically) -- 4 Liability: The Road Toward Becoming Active Patients -- 5 Communication Through eHealth -- 6 Health Social Networks -- 7 Challenges to eHealth Usages and Possible Solutions -- 8 Conclusion -- References -- Chapter 5: Predictive Precision Medicine: Towards the Computational Challenge -- 1 Introduction -- 2 Predictive Medicine and Precision Medicine. 3 Imaging Techniques, Artificial Intelligence and Machine Learning -- 3.1 Imaging Techniques -- 3.2 Artificial Intelligence and Machine Learning -- 3.3 Medical Imaging and Machine Learning -- 4 Predictive Precision Medicine in Neurodegenerative Diseases -- 4.1 Current Application: From Dementias to Parkinson's Disease -- 5 Conclusion -- References -- Chapter 6: Participatory Aspects of ICT Infrastructures for Cancer Management -- 1 Introduction -- 2 Participatory Aspects for Cancer Management -- 2.1 From Personalized to Participatory Medicine -- 2.2 Critical Factors of Participatory Medicine -- 2.3 Psychological Factors as Moderators of Participatory Medicine -- 3 ICT Solutions from Relevant EU Projects -- 3.1 iManageCancer -- 3.1.1 Technological Contribution -- 3.1.2 Participatory Aspect of the Developed Solution -- 3.1.3 Lessons Learnt -- 3.2 MyHealthAvatar -- 3.2.1 Technological Contribution -- 3.2.2 Participatory Aspect of the Developed Solution -- 3.2.3 Lessons Learnt -- 3.3 p-Medicine -- 3.3.1 Technological Contribution -- 3.3.2 Participatory Aspect of the Developed Solution -- 3.3.3 Lessons Learnt -- 3.4 EURECA -- 3.4.1 Technological Contribution -- 3.4.2 Participatory Aspects of the Developed Solution -- 3.4.3 Lessons Learnt -- 3.5 INTEGRATE -- 3.5.1 Technological Contribution -- 3.5.2 Participatory Aspect of the Developed Solution -- 3.5.3 Lessons Learnt -- 4 Conclusions and Guidelines for Future Development -- References -- Chapter 7: Psycho-cognitive Factors Orienting eHealth Development and Evaluation -- 1 The P5 and the Personomics Approach -- 2 The Key Elements for the P5-Personomics Approach -- 3 Solutions Come from the eHealth Apps -- 4 Digital Health in the Patient's Journey -- 4.1 A Possible Scenario -- 5 The Importance of Patient Education -- 6 Persuasive Design Technology -- 7 Conclusion -- References. Part III: Important Aspects for P5 Technologies Development and Utilization -- Chapter 8: Role of Next-Generation Sequencing Technologies in Personalized Medicine -- 1 Historic Background of DNA Sequencing -- 1.1 The NGS Revolution in the Context of Precision Medicine -- 2 Technical Aspects: From Sanger Sequencing to NGS -- 2.1 Library Preparation and Amplification -- 2.2 Sequencing -- 2.3 Data Analysis -- 3 NGS Methods: Genomics, Transcriptomics, and Epigenomics -- 3.1 Genomics -- 3.2 Transcriptomics -- 3.3 Epigenomics -- 4 NGS Applications for a Personalized Oncology -- 4.1 Detection of Driver Alterations and Resistance -- 4.1.1 Lung Cancer -- 4.1.2 Breast Cancer -- 4.1.3 Carcinoma of Unknown Primary Site -- 4.2 Biomarkers -- 4.2.1 Homologous Recombination Deficiency -- 4.2.2 Microsatellite Instability -- 4.2.3 Tumor Mutational Burden -- 4.3 Liquid Biopsy -- 4.3.1 Early Diagnosis of Primary Disease -- 4.3.2 Early Detection of Relapse -- 4.3.3 Detection of Driver/Resistance Mutations and Real-Time Monitoring of Therapies -- 4.3.4 Characterization of Tumor Heterogeneity -- 4.3.5 CTCs and ctDNA Analysis -- 5 NGS Implementation in Clinical Practice: Challenges and Limitations -- References -- Chapter 9: User-Centered Design Approaches and Methods for P5 eHealth -- 1 Introduction -- 2 From Ergonomics to User-Centered Design -- 2.1 Interaction Factors -- 2.2 Motivation and Emotion -- 2.2.1 Motivation in Design -- 2.2.2 Emotion in Design -- 2.3 Context -- 2.3.1 Individual and Psychosocial Dimensions of Context -- 2.3.2 Cultural and Relational Dimensions of Context -- 2.3.3 Physical and Material Dimension of Context -- 3 User-Centered Design and P5 eHealth -- References -- Chapter 10: Data Protection and Ethical Issues in European P5 eHealth -- 1 Introduction -- 2 eHealth in the European Union: From Advancement of Innovation to Data Protection Concerns. 3 The GDPR and Its Impact on eHealth Research and Innovation -- 3.1 The Accountability Principle and its Implications -- 3.2 Pseudonymization and Anonymization of Sensitive Data -- 3.3 The "Right Balance" Between Innovation and Protection of Individuals' Rights and Interests? -- 4 Ethical Issues in eHealth Technologies -- 4.1 Online eHealth (Self-Management) Tools -- 4.2 Monitoring Techniques -- 4.3 New and Unconventional eHealth Technologies -- 5 Conclusions -- References. |
author_facet |
Pravettoni, Gabriella. Triberti, Stefano. |
author_variant |
g p gp |
author2 |
Triberti, Stefano. |
author2_variant |
s t st |
author2_role |
TeilnehmendeR |
author_sort |
Pravettoni, Gabriella. |
title |
P5 EHealth : an Agenda for the Health Technologies of the Future. |
title_sub |
an Agenda for the Health Technologies of the Future. |
title_full |
P5 EHealth : an Agenda for the Health Technologies of the Future. |
title_fullStr |
P5 EHealth : an Agenda for the Health Technologies of the Future. |
title_full_unstemmed |
P5 EHealth : an Agenda for the Health Technologies of the Future. |
title_auth |
P5 EHealth : an Agenda for the Health Technologies of the Future. |
title_new |
P5 EHealth : |
title_sort |
p5 ehealth : an agenda for the health technologies of the future. |
publisher |
Springer International Publishing AG, |
publishDate |
2019 |
physical |
1 online resource (191 pages) |
edition |
1st ed. |
contents |
P5 eHealth: An Agenda for the Health Technologies of the Future -- Preface -- Contents -- About the Editors -- Part I: Foundations for P5 eHealth -- Chapter 1: A "P5" Approach to Healthcare and Health Technology -- 1 Introduction -- 2 P5 Medicine -- 3 eHealth -- 3.1 Strengths of eHealth -- 3.2 Criticalities of eHealth and Emerging Challenges -- 4 Conclusion -- References -- Chapter 2: The Development of iManageCancer: The Experience of a Personalised eHealth Platform for Cancer Patients' Empowerment -- 1 Introduction -- 2 The IManageCancer Platform -- 2.1 My HealthAvatar for iManageCancer -- 2.2 iManageMyHealth -- 2.3 iManageCancer Portal iPHR -- 2.4 Game for Adults -- 3 iManageCancer Within the p5 Approach -- 4 Conclusion -- References -- Part II: The 5 Ps and eHealth -- Chapter 3: The Prevention of Chronic Diseases Through eHealth: A Practical Overview -- 1 Introduction -- 2 Risk Factors for Chronic Diseases -- 3 Primary, Secondary, and Tertiary eHealth Prevention -- 4 Population-Based vs. Individual-Based eHealth Prevention -- 5 eHealth Behavioral Change Interventions -- 6 Strategies of eHealth Prevention -- 7 Conclusion -- References -- Chapter 4: An Introduction to Personalized eHealth -- 1 Introduction -- 1.1 What Are the News of Personalized Medicine? -- 1.2 A Brief History -- 2 The Development of Personalized Medicine -- 2.1 Treatments -- 2.2 Diagnosis and Risk Prediction -- 2.3 Doctor-Patient Communication -- 2.4 Disease/Illness Management -- 3 The Role of eHealth (and mHealth Specifically) -- 4 Liability: The Road Toward Becoming Active Patients -- 5 Communication Through eHealth -- 6 Health Social Networks -- 7 Challenges to eHealth Usages and Possible Solutions -- 8 Conclusion -- References -- Chapter 5: Predictive Precision Medicine: Towards the Computational Challenge -- 1 Introduction -- 2 Predictive Medicine and Precision Medicine. 3 Imaging Techniques, Artificial Intelligence and Machine Learning -- 3.1 Imaging Techniques -- 3.2 Artificial Intelligence and Machine Learning -- 3.3 Medical Imaging and Machine Learning -- 4 Predictive Precision Medicine in Neurodegenerative Diseases -- 4.1 Current Application: From Dementias to Parkinson's Disease -- 5 Conclusion -- References -- Chapter 6: Participatory Aspects of ICT Infrastructures for Cancer Management -- 1 Introduction -- 2 Participatory Aspects for Cancer Management -- 2.1 From Personalized to Participatory Medicine -- 2.2 Critical Factors of Participatory Medicine -- 2.3 Psychological Factors as Moderators of Participatory Medicine -- 3 ICT Solutions from Relevant EU Projects -- 3.1 iManageCancer -- 3.1.1 Technological Contribution -- 3.1.2 Participatory Aspect of the Developed Solution -- 3.1.3 Lessons Learnt -- 3.2 MyHealthAvatar -- 3.2.1 Technological Contribution -- 3.2.2 Participatory Aspect of the Developed Solution -- 3.2.3 Lessons Learnt -- 3.3 p-Medicine -- 3.3.1 Technological Contribution -- 3.3.2 Participatory Aspect of the Developed Solution -- 3.3.3 Lessons Learnt -- 3.4 EURECA -- 3.4.1 Technological Contribution -- 3.4.2 Participatory Aspects of the Developed Solution -- 3.4.3 Lessons Learnt -- 3.5 INTEGRATE -- 3.5.1 Technological Contribution -- 3.5.2 Participatory Aspect of the Developed Solution -- 3.5.3 Lessons Learnt -- 4 Conclusions and Guidelines for Future Development -- References -- Chapter 7: Psycho-cognitive Factors Orienting eHealth Development and Evaluation -- 1 The P5 and the Personomics Approach -- 2 The Key Elements for the P5-Personomics Approach -- 3 Solutions Come from the eHealth Apps -- 4 Digital Health in the Patient's Journey -- 4.1 A Possible Scenario -- 5 The Importance of Patient Education -- 6 Persuasive Design Technology -- 7 Conclusion -- References. Part III: Important Aspects for P5 Technologies Development and Utilization -- Chapter 8: Role of Next-Generation Sequencing Technologies in Personalized Medicine -- 1 Historic Background of DNA Sequencing -- 1.1 The NGS Revolution in the Context of Precision Medicine -- 2 Technical Aspects: From Sanger Sequencing to NGS -- 2.1 Library Preparation and Amplification -- 2.2 Sequencing -- 2.3 Data Analysis -- 3 NGS Methods: Genomics, Transcriptomics, and Epigenomics -- 3.1 Genomics -- 3.2 Transcriptomics -- 3.3 Epigenomics -- 4 NGS Applications for a Personalized Oncology -- 4.1 Detection of Driver Alterations and Resistance -- 4.1.1 Lung Cancer -- 4.1.2 Breast Cancer -- 4.1.3 Carcinoma of Unknown Primary Site -- 4.2 Biomarkers -- 4.2.1 Homologous Recombination Deficiency -- 4.2.2 Microsatellite Instability -- 4.2.3 Tumor Mutational Burden -- 4.3 Liquid Biopsy -- 4.3.1 Early Diagnosis of Primary Disease -- 4.3.2 Early Detection of Relapse -- 4.3.3 Detection of Driver/Resistance Mutations and Real-Time Monitoring of Therapies -- 4.3.4 Characterization of Tumor Heterogeneity -- 4.3.5 CTCs and ctDNA Analysis -- 5 NGS Implementation in Clinical Practice: Challenges and Limitations -- References -- Chapter 9: User-Centered Design Approaches and Methods for P5 eHealth -- 1 Introduction -- 2 From Ergonomics to User-Centered Design -- 2.1 Interaction Factors -- 2.2 Motivation and Emotion -- 2.2.1 Motivation in Design -- 2.2.2 Emotion in Design -- 2.3 Context -- 2.3.1 Individual and Psychosocial Dimensions of Context -- 2.3.2 Cultural and Relational Dimensions of Context -- 2.3.3 Physical and Material Dimension of Context -- 3 User-Centered Design and P5 eHealth -- References -- Chapter 10: Data Protection and Ethical Issues in European P5 eHealth -- 1 Introduction -- 2 eHealth in the European Union: From Advancement of Innovation to Data Protection Concerns. 3 The GDPR and Its Impact on eHealth Research and Innovation -- 3.1 The Accountability Principle and its Implications -- 3.2 Pseudonymization and Anonymization of Sensitive Data -- 3.3 The "Right Balance" Between Innovation and Protection of Individuals' Rights and Interests? -- 4 Ethical Issues in eHealth Technologies -- 4.1 Online eHealth (Self-Management) Tools -- 4.2 Monitoring Techniques -- 4.3 New and Unconventional eHealth Technologies -- 5 Conclusions -- References. |
isbn |
9783030279943 9783030279936 |
callnumber-first |
R - Medicine |
callnumber-subject |
R - General Medicine |
callnumber-label |
R726 |
callnumber-sort |
R 3726.7 |
genre |
Electronic books. |
genre_facet |
Electronic books. |
url |
https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=5987458 |
illustrated |
Not Illustrated |
oclc_num |
1135670456 |
work_keys_str_mv |
AT pravettonigabriella p5ehealthanagendaforthehealthtechnologiesofthefuture AT tribertistefano p5ehealthanagendaforthehealthtechnologiesofthefuture |
status_str |
n |
ids_txt_mv |
(MiAaPQ)5005987458 (Au-PeEL)EBL5987458 (OCoLC)1135670456 |
carrierType_str_mv |
cr |
is_hierarchy_title |
P5 EHealth : an Agenda for the Health Technologies of the Future. |
author2_original_writing_str_mv |
noLinkedField |
marc_error |
Info : MARC8 translation shorter than ISO-8859-1, choosing MARC8. --- [ 856 : z ] |
_version_ |
1792331055367192577 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>08305nam a22004213i 4500</leader><controlfield tag="001">5005987458</controlfield><controlfield tag="003">MiAaPQ</controlfield><controlfield tag="005">20240229073833.0</controlfield><controlfield tag="006">m o d | </controlfield><controlfield tag="007">cr cnu||||||||</controlfield><controlfield tag="008">240229s2019 xx o ||||0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783030279943</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9783030279936</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(MiAaPQ)5005987458</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(Au-PeEL)EBL5987458</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1135670456</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">MiAaPQ</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="e">pn</subfield><subfield code="c">MiAaPQ</subfield><subfield code="d">MiAaPQ</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">R726.7</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Pravettoni, Gabriella.</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">P5 EHealth :</subfield><subfield code="b">an Agenda for the Health Technologies of the Future.</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1st ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cham :</subfield><subfield code="b">Springer International Publishing AG,</subfield><subfield code="c">2019.</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©2020.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (191 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">P5 eHealth: An Agenda for the Health Technologies of the Future -- Preface -- Contents -- About the Editors -- Part I: Foundations for P5 eHealth -- Chapter 1: A "P5" Approach to Healthcare and Health Technology -- 1 Introduction -- 2 P5 Medicine -- 3 eHealth -- 3.1 Strengths of eHealth -- 3.2 Criticalities of eHealth and Emerging Challenges -- 4 Conclusion -- References -- Chapter 2: The Development of iManageCancer: The Experience of a Personalised eHealth Platform for Cancer Patients' Empowerment -- 1 Introduction -- 2 The IManageCancer Platform -- 2.1 My HealthAvatar for iManageCancer -- 2.2 iManageMyHealth -- 2.3 iManageCancer Portal iPHR -- 2.4 Game for Adults -- 3 iManageCancer Within the p5 Approach -- 4 Conclusion -- References -- Part II: The 5 Ps and eHealth -- Chapter 3: The Prevention of Chronic Diseases Through eHealth: A Practical Overview -- 1 Introduction -- 2 Risk Factors for Chronic Diseases -- 3 Primary, Secondary, and Tertiary eHealth Prevention -- 4 Population-Based vs. Individual-Based eHealth Prevention -- 5 eHealth Behavioral Change Interventions -- 6 Strategies of eHealth Prevention -- 7 Conclusion -- References -- Chapter 4: An Introduction to Personalized eHealth -- 1 Introduction -- 1.1 What Are the News of Personalized Medicine? -- 1.2 A Brief History -- 2 The Development of Personalized Medicine -- 2.1 Treatments -- 2.2 Diagnosis and Risk Prediction -- 2.3 Doctor-Patient Communication -- 2.4 Disease/Illness Management -- 3 The Role of eHealth (and mHealth Specifically) -- 4 Liability: The Road Toward Becoming Active Patients -- 5 Communication Through eHealth -- 6 Health Social Networks -- 7 Challenges to eHealth Usages and Possible Solutions -- 8 Conclusion -- References -- Chapter 5: Predictive Precision Medicine: Towards the Computational Challenge -- 1 Introduction -- 2 Predictive Medicine and Precision Medicine.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">3 Imaging Techniques, Artificial Intelligence and Machine Learning -- 3.1 Imaging Techniques -- 3.2 Artificial Intelligence and Machine Learning -- 3.3 Medical Imaging and Machine Learning -- 4 Predictive Precision Medicine in Neurodegenerative Diseases -- 4.1 Current Application: From Dementias to Parkinson's Disease -- 5 Conclusion -- References -- Chapter 6: Participatory Aspects of ICT Infrastructures for Cancer Management -- 1 Introduction -- 2 Participatory Aspects for Cancer Management -- 2.1 From Personalized to Participatory Medicine -- 2.2 Critical Factors of Participatory Medicine -- 2.3 Psychological Factors as Moderators of Participatory Medicine -- 3 ICT Solutions from Relevant EU Projects -- 3.1 iManageCancer -- 3.1.1 Technological Contribution -- 3.1.2 Participatory Aspect of the Developed Solution -- 3.1.3 Lessons Learnt -- 3.2 MyHealthAvatar -- 3.2.1 Technological Contribution -- 3.2.2 Participatory Aspect of the Developed Solution -- 3.2.3 Lessons Learnt -- 3.3 p-Medicine -- 3.3.1 Technological Contribution -- 3.3.2 Participatory Aspect of the Developed Solution -- 3.3.3 Lessons Learnt -- 3.4 EURECA -- 3.4.1 Technological Contribution -- 3.4.2 Participatory Aspects of the Developed Solution -- 3.4.3 Lessons Learnt -- 3.5 INTEGRATE -- 3.5.1 Technological Contribution -- 3.5.2 Participatory Aspect of the Developed Solution -- 3.5.3 Lessons Learnt -- 4 Conclusions and Guidelines for Future Development -- References -- Chapter 7: Psycho-cognitive Factors Orienting eHealth Development and Evaluation -- 1 The P5 and the Personomics Approach -- 2 The Key Elements for the P5-Personomics Approach -- 3 Solutions Come from the eHealth Apps -- 4 Digital Health in the Patient's Journey -- 4.1 A Possible Scenario -- 5 The Importance of Patient Education -- 6 Persuasive Design Technology -- 7 Conclusion -- References.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Part III: Important Aspects for P5 Technologies Development and Utilization -- Chapter 8: Role of Next-Generation Sequencing Technologies in Personalized Medicine -- 1 Historic Background of DNA Sequencing -- 1.1 The NGS Revolution in the Context of Precision Medicine -- 2 Technical Aspects: From Sanger Sequencing to NGS -- 2.1 Library Preparation and Amplification -- 2.2 Sequencing -- 2.3 Data Analysis -- 3 NGS Methods: Genomics, Transcriptomics, and Epigenomics -- 3.1 Genomics -- 3.2 Transcriptomics -- 3.3 Epigenomics -- 4 NGS Applications for a Personalized Oncology -- 4.1 Detection of Driver Alterations and Resistance -- 4.1.1 Lung Cancer -- 4.1.2 Breast Cancer -- 4.1.3 Carcinoma of Unknown Primary Site -- 4.2 Biomarkers -- 4.2.1 Homologous Recombination Deficiency -- 4.2.2 Microsatellite Instability -- 4.2.3 Tumor Mutational Burden -- 4.3 Liquid Biopsy -- 4.3.1 Early Diagnosis of Primary Disease -- 4.3.2 Early Detection of Relapse -- 4.3.3 Detection of Driver/Resistance Mutations and Real-Time Monitoring of Therapies -- 4.3.4 Characterization of Tumor Heterogeneity -- 4.3.5 CTCs and ctDNA Analysis -- 5 NGS Implementation in Clinical Practice: Challenges and Limitations -- References -- Chapter 9: User-Centered Design Approaches and Methods for P5 eHealth -- 1 Introduction -- 2 From Ergonomics to User-Centered Design -- 2.1 Interaction Factors -- 2.2 Motivation and Emotion -- 2.2.1 Motivation in Design -- 2.2.2 Emotion in Design -- 2.3 Context -- 2.3.1 Individual and Psychosocial Dimensions of Context -- 2.3.2 Cultural and Relational Dimensions of Context -- 2.3.3 Physical and Material Dimension of Context -- 3 User-Centered Design and P5 eHealth -- References -- Chapter 10: Data Protection and Ethical Issues in European P5 eHealth -- 1 Introduction -- 2 eHealth in the European Union: From Advancement of Innovation to Data Protection Concerns.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">3 The GDPR and Its Impact on eHealth Research and Innovation -- 3.1 The Accountability Principle and its Implications -- 3.2 Pseudonymization and Anonymization of Sensitive Data -- 3.3 The "Right Balance" Between Innovation and Protection of Individuals' Rights and Interests? -- 4 Ethical Issues in eHealth Technologies -- 4.1 Online eHealth (Self-Management) Tools -- 4.2 Monitoring Techniques -- 4.3 New and Unconventional eHealth Technologies -- 5 Conclusions -- References.</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="590" ind1=" " ind2=" "><subfield code="a">Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. </subfield></datafield><datafield tag="655" ind1=" " ind2="4"><subfield code="a">Electronic books.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Triberti, Stefano.</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="a">Pravettoni, Gabriella</subfield><subfield code="t">P5 EHealth: an Agenda for the Health Technologies of the Future</subfield><subfield code="d">Cham : Springer International Publishing AG,c2019</subfield><subfield code="z">9783030279936</subfield></datafield><datafield tag="797" ind1="2" ind2=" "><subfield code="a">ProQuest (Firm)</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=5987458</subfield><subfield code="z">Click to View</subfield></datafield></record></collection> |